Biotech · Private company
Innocrin Pharmaceutical
Track this companyFree. Adds Innocrin Pharmaceutical to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- SeviteronelPhase 2 · Cancer of the BreastClinicalTrials.gov · fetched Nov 12, 2026
- Seviteronel: given orally once daily in 28 day cyclesPhase 2 · Castration-resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- Seviteronel: given orally once daily in 28-day cyclesPhase 2 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- VT-464: given orally once daily in 28 day cyclesPhase 2 · Castration-resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448)PHASE1_PHASE2 · COMPLETED · started Aug 1, 2015ClinicalTrials.gov NCT02580448 · fetched Nov 12, 2026
- Once-daily Oral Seviteronel in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone.PHASE2 · COMPLETED · started May 1, 2015ClinicalTrials.gov NCT02445976 · fetched Nov 12, 2026
- A Study to Evaluate Once-Daily Oral VT-464 in Patients With Castration-Resistant Prostate CancerPHASE1_PHASE2 · COMPLETED · started Jun 1, 2014ClinicalTrials.gov NCT02361086 · fetched Nov 12, 2026
- A Study to Evaluate Oral VT-464 in Patients With Castration-Resistant Prostate CancerPHASE2 · COMPLETED · started Dec 1, 2011ClinicalTrials.gov NCT02012920 · fetched Nov 12, 2026